TradingView
RocketTickers
14 de Ago de 2018 16:50

Motif Bio Announces FDA Acceptance of New Drug Application with  Viés de alta

NASDAQ:MTFB1D

Descrição

⋅
MTFB: Motif Bio plc
2018-08-14 02:00:00
Motif Bio Announces FDA Acceptance of New Drug Application with Priority Review for Iclaprim for Treatment of Acute Bacterial Skin and Skin Structure Infections
Beyond Technical Analysis
Mais